Anika Therapeutics Inc/ US0352551081 /
2024-04-19 10:00:00 PM | Chg. +0.4100 | Volume | Bid10:02:18 PM | Ask10:02:18 PM | High | Low |
---|---|---|---|---|---|---|
25.8400USD | +1.61% | 49,278 Turnover: 806,589.2145 |
24.9200Bid Size: 100 | 26.7500Ask Size: 100 | 25.9700 | 25.4550 |
GlobeNewswire
02-27
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
GlobeNewswire
02-13
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Ar...
GlobeNewswire
2023-11-28
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyalur...
GlobeNewswire
2023-11-02
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on G...
GlobeNewswire
2023-10-10
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
GlobeNewswire
2023-09-19
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System duri...
GlobeNewswire
2023-08-17
Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based ...
GlobeNewswire
2022-03-23
Anika to Showcase its Transformation into a Global Leader in Joint Preservation during the 2022 AAOS...
GlobeNewswire
2022-02-08
Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022